D69.1

Qualitative platelet defects

Risk-adjusting (HCC)Billable code

HCC risk adjustment mapping

CMS-HCC V28

HCC112

Immune Thrombocytopenia and Specified Coagulation Defects and Hemorrhagic Conditions

CMS-HCC ESRD V24

HCC48

Coagulation Defects and Other Specified Hematological Disorders

Coding notes

Excludes 1 never coded together · Excludes 2 may co-exist

This code · D69.1

Excludes 1

hemolytic-uremic syndrome (D59.3-)

Excludes 2

von Willebrand disease (D68.0-)

Synonyms

Bernard-Soulier [giant platelet] syndrome Glanzmann's disease Grey platelet syndrome Thromboasthenia (hemorrhagic) (hereditary) Thrombocytopathy

Inherited from D69Purpura and other hemorrhagic conditions

Excludes 1

benign hypergammaglobulinemic purpura (D89.0) cryoglobulinemic purpura (D89.1) essential (hemorrhagic) thrombocythemia (D47.3) hemorrhagic thrombocythemia (D47.3) purpura fulminans (D65) thrombotic thrombocytopenic purpura (M31.19) Waldenström hypergammaglobulinemic purpura (D89.0)

Inherited from chapter 3Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Excludes 2

autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)

Official Guidelines for D69.1

FY 2026 ›

I.C.3Chapter-specific guidanceChapter 3: Disease of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)

Find D69.1 in the alphabetic index

17 index paths lead to this code